Published: 28-09-2021 13:32 | Updated: 28-09-2021 15:53

Current calls, week 39, 2021

Tips from Grants Office regarding current calls

Swedish and Nordic calls


Grants for research and development projects – Stiftelsen Promobilia

These promote the development and production of technical aids that enable persons with disabilities to have a more active life. Grants are worth between SEK 100,000 and SEK 500,000 each.

Closing date: 15 October 2021

Further information 


Forskningsmedel – Fonden för Psykisk Hälsa

Fonden för Psykisk Hälsa stödjer psykiatrisk och psykologiskforskning i Sverige och delar ut forskningsmedel en gång per år. Forskningsmedel delas ut till registrerade doktorander som har genomfört halvtidskontroll eller till postdoktorala forskare inom fem år fråndisputation, inom områdena psykologi och psykiatri. Vi delar inte ut forskningsmedeltill privatpersoner, företag eller organisationer. Bedömning av inkomna ansökningar görs av fondens vetenskapliga råd.

Closing date: 15 October 2021

Further information


Forskningsmedel – Spädbarnsfonden

Spädbarnsfonden utlyser en gång per år medel för stöd till forskning med syfte att förebygga att barn dör före födelsen eller under spädbarnsperioden. Forskningen kan även handla om att förbättra bemötandet av drabbade föräldrar och närstående. Anslag kan sökas för biomedicinsk forskning, inom fostermedicin och nyföddhetsvård, och för omvårdnads- och vårdvetenskaplig samt psykosocial forskning.

Closing date: 31 October 2021

Further information


Grant for Research Programme, Biodiversity and the Financial System - Mistra

The Swedish Foundation for Strategic Environmental Research (Mistra) invites research groups, jointly with the finance industry, other businesses, civil society organizations, the public sector and other stakeholders, to submit proposals for a new research programme. The purpose of the call is to investigate how research and innovation can support the alignment of biodiversity’s needs with the financial system. In line with Mistra’s statutes, the research programme shall be of strategic environmental importance.

Closing date: 20 December 2021

Further information 


VINNOVA – MSCA Employment: Attract, integrate and retain international excellence

Many international researchers who are in Sweden with funding from the EU´s Marie Skłodowska-Curie Actions move from Sweden after completing the MSCA- project. This opportunity makes it easier for employers in business, research institutes and public actors (outside the university and college sphere) to hire a researcher who has completed a MSCA- project in Sweden. It is an opportunity to meet the organizations´ need for cutting-edge expertise in researchers´ special areas and create conditions for researchers to stay in Sweden.

Closing date: 5th October 2021

Further information

European calls


ASPIRE global obesity grant - Pfizer

Pfizer invites letters of intent for its ASPIRE global obesity grant. This supports basic science, preclinical research and clinical research, animal experimentation related to human biology and physiological, cellular, molecular and translational research regarding obesity.

Applicants must have a medical or postdoctoral degree, an advanced nursing degree or a degree in pharmacy, physiotherapy, or social work and be affiliated with a host institution.

Closing date: 5 November 2021

Further information (Pfizer web)

Further information (Program in PDF)


Ataxia grants - Ataxia UK

Ataxia UK invites applications for its grants. These support relevant research on ataxia. Conditions such as Friedreich’s ataxia, the spinocerebellar ataxias and other cerebellar ataxias including idiopathic ones are within remit. Research into ataxia telangiectasia, or ataxia due to traumas such as stroke, head injury and due to toxicity, is ineligible.

Academic institutions, private sector research companies, suitably qualified individuals and collaborative groups formed from a combination of the above may apply. Proposals are accepted from principal applicants based in the UK or in a European country that is part of euro-ATAXIA, namely Belgium, Denmark, Finland, France, Germany, Israel, Italy, the Netherlands, Norway, Spain, Sweden and Switzerland.

Closing date: 15 October 2021

Further information 


EHRA training fellowships – arrhythmias and cardiac pacing with emphasis on implantable cardioverter defibrillators and cardiac resynchronisation therapy - European Society of Cardiology

The European Society of Cardiology invites applications for its EHRA training fellowships in arrhythmias and cardiac pacing with emphasis on implantable cardioverter defibrillators and cardiac resynchronisation therapy. These enable physicians to acquire specialised training in cardiac pacing in a regular ESC member country preferably outside their home country.

Closing date: 15 November 2021

Further information 


Osteology researcher grants - Osteology Foundation

The Osteology Foundation invites applications for its osteology research grants. These support research on oral tissue regeneration. Topics may include: clinical aspects of hard and soft tissue biology; novel bone and soft tissue substitute materials; local factors affecting oral tissue regeneration; systemic diseases with an impact on oral tissue regeneration; pharmacological aspects of oral tissue regeneration; inflammatory conditions, such as periodontitis and peri-implantitis.

Applications are open to advanced researchers in the field of oral tissue regeneration and young researchers currently undergoing postgraduate education or within three years thereafter.

Closing date: 1 December 2021

Further information 


International prize - Fyssen Foundation

The Fyssen Foundation invites nominations for its international prize. This recognises scientific inquiry into cognitive mechanisms, including thought and reasoning, which underlie animal and human behaviour, their biological and cultural bases, and phylogenetic and ontogenetic development.

Researchers may have a background in the fields of ethnology, psychology, neurobiology, human palaeontology or archaeology. The prize is worth €100,000.

Closing date: 5 November 2021

Further information

US calls


Federal Funding agencies


Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional), NIH

The purpose of this Funding Opportunity Announcement (FOA) is to support collaborative research projects designed to address adverse sequelae of cancer therapies that persist and become chronic comorbidities or develop as delayed posttreatment effects. This FOA supports basic, translational, and/or clinical research projects that seek to identify the mechanisms of therapy-induced adverse sequelae, clinically characterize the adverse sequelae, or translate the mechanistic understanding into therapeutic approaches to prevent or minimize the development of long-term sequelae. Research projects should focus on 1) mechanistic studies with translational endpoints; and/or 2) longitudinal clinical phenotyping to identify and validate clinical endpoints (biomarkers, imaging, patient-reported outcomes, or combined elements) for future use in clinical trials that will evaluate the efficacy of interventions designed to prevent or reduce specific adverse sequelae.

Deadline: Standard dates apply until November 6, 2024. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-21-329

Further information


Mood and Psychosis Symptoms during the Menopause Transition (R01 & R21 Clinical Trial Optional), NIH

The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications that will advance mechanistic and translational research on the onset and worsening of mood and psychotic disorders during the menopausal transition (or perimenopause). In particular, NIMH seeks research that will advance understanding of the underlying neurobiological and behavioral mechanisms of mood disruption and psychosis during the menopausal transition and that will identify novel targets for future mental health interventions or prevention efforts.

This FOA uses the R01 grant mechanism, while the companion FOA (PAR-22-036 ) uses the R21 mechanism. Investigators proposing high risk/high reward projects, projects that lack preliminary data, or studies that utilize existing data may wish to apply using the R21 mechanism, while applicants with preliminary data who seek longer-term funding may wish to apply using the R01 mechanism.

Deadline: Standard dates apply until January 8, 2025. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-22-035 (R01); PAR-22-036 (R21).

Further information; PAR-22-035 (R01PAR-22-036 (R21) 




Clinic and Laboratory Integration Program (CLIP), Cancer Research Institute, US

The Cancer Research Institute is requesting letters of intent for its Clinic and Laboratory Integration program (CLIP). CRI offers CLIP grants to qualified scientists who are working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. The development of new and effective cancer treatment requires the translation of basic laboratory discoveries into novel therapies that can be tested in patients. This area of translational
research-where laboratory findings move into clinical testing and where questions from clinical studies are brought back into the lab-is critical to bringing new and better immunotherapies to

The grant will support basic, pre-clinical, and translational research that will provide information that can be directly applied to optimizing cancer immunotherapy in the clinic. Funding: 200,000 USD over two years.

Deadline: December 1, 2021 (LOI), March 1, 2022 (Full proposal).

Further information 


2021-2022 Request for Proposals, Melanoma Research Alliance (MRA), US

The Melanoma Research Alliance (MRA) is pleased to announce a Request for Proposals (RFP) for pre-clinical, translational, and early clinical research with the potential to produce unusually high impact, near-term advancements in melanoma prevention, detection, diagnosis, staging, and treatment. The 2021 - 2022 award cycle, is anticipated to support at least $12.8 million in new funding. Proposals will be accepted for Team Science, Academic-Industry Partnership, Young Investigator, and Pilot Awards. 


Young Investigator Awards aim to attract early career faculty with original ideas into the field of melanoma, thereby recruiting and supporting the next generation of melanoma research leaders. Awardees will be provided funding to accomplish innovative and original, preclinical, translational, and/or early clinical research projects. Young Investigators are scientists within the first five years of their first academic faculty appointment. A mentorship commitment from a senior investigator is required.

Term: 3 Years

Amount: Up to $85,000 per year for three years (up to $255,000 total)

Applicant Eligibility Checklist due November 3, 2021

Full proposals due 11:59 p.m. Eastern Time, November 17, 2021


Pilot Awards support senior investigators who propose potentially transformative ideas that do not have extensive preliminary data but articulate a clear hypothesis and translational goals. Resources for such "high-risk, high-reward" projects are important to establish proof-of-concept, which may then leverage additional funding through more traditional avenues.

Full proposals due 11:59 p.m. Eastern Time, November 17, 2021

Term: 2 Years

Amount: Up to $50,000 per year for two years (up to $100,000 total)

Further information